Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Chibio Biotech is a specialized biotechnology company focused on the research, development, and manufacturing of natural biopolymers and their derivatives. Headquartered in Qingdao, China, the company has established itself as a leading supplier of high-purity chitosan, glucosamine, and hyaluronic acid derived from both animal and non-animal sources. Their product portfolio serves diverse sectors including pharmaceuticals, healthcare, cosmetics, and food industries, with a particular emphasis on fungal-derived ingredients for the vegan market. Chibio Biotech integrates advanced extraction and enzymatic hydrolysis technologies to produce functional ingredients used in wound dressings, joint health supplements, and skincare formulations. The company operates under strict quality management systems to provide customized solutions and raw materials to a global clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Chibio Biotech.